Read + Share
Kaku Y, Kosugi Y, Uriu K, Ito J, et al. Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against
omicron subvariants including EG.5. Lancet Infect Dis 2023 Sep 11:S1473-3099(23)00553.
PMID: 37708910
|
 |
|
Kaku Y, Kosugi Y, Uriu K, Ito J, et al. Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against
omicron subvariants including EG.5. Lancet Infect Dis 2023 Sep 11:S1473-3099(23)00553.
PMID: 37708910
|
|
|
|